nach oben

Cognitive Therapy and Research

Erschienen in:

01.08.2015 | Original Article

The Use of Motivation Enhancement Therapy to Increase Utilization of a Preventative Intervention for Anxiety Sensitivity

verfasst von: Kristina J. Korte, Norman B. Schmidt

Erschienen in: Cognitive Therapy and Research | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Anxiety sensitivity (AS), the fear of anxiety and its potential consequences, places individuals at an increased risk for the development of anxiety disorders. While elevated AS is correctable, often through very brief interventions, individuals high in AS may be unaware of the risks associated with this risk factor and, therefore, may be unaware or unmotivated to address this potential risk. The purpose of the present investigation was to examine the use of motivation enhancement therapy (MET) to enhance motivation to utilize a preventive intervention in a non-intervention seeking population with elevated levels of AS. We examined this issue in a randomized controlled pilot study. Participants (N = 23) were randomized to one of two groups: (1) a MET group (n = 12) group or (2) a control group focused on healthy behaviors (n = 11). Those in the MET group received MET focused on enhancing motivation to reduce AS, whereas those in the control group received psychoeducation about health and general well being. At the end of the study, all of the participants were given the option to receive a computerized intervention previously found to be effective at reducing AS. Results revealed that the MET group had significant changes in motivation to change anxiety and motivation to attend the AS preventative intervention. Moreover, 50 % of individuals in the MET group completed the preventative intervention in comparison to 0 % in the control group. Implications of the findings are discussed.

Bernstein, A., Zvolensky, M. J., Feldner, M. T., Lewis, S. F., & Leen-Feldner, E. W. (2005). Anxiety sensitivity taxonicity: A concurrent test of cognitive vulnerability for post-traumatic stress symptomatology among young adults. Cognitive Behavior Therapy, 34, 229–241.CrossRef

Brown, M., Smits, J. A. J., Powers, M. B., & Telch, M. J. (2003). Differential sensitivity of the three ASI factors in predicting panic disorder patients’ subjective and behavioral response to hyperventilation challenge. Journal of Anxiety Disorders, 17, 583–591.PubMedCrossRef

Buckner J. D. (2007). MET for CBT for social anxiety treatment manual and research protocol. Florida State University. Unpublished manuscript.

Buckner, J. D., & Schmidt, N. B. (2009). A randomized pilot study of motivational enhancement therapy to increase utilization of cognitive-behavioral therapy for social anxiety. Behaviour Research and Therapy, 47, 710–715.PubMedCrossRef

Buckner, J. D., Ledley, D. R., Heimberg, R. G., & Schmidt, N. B. (2008). Treating comorbid social anxiety and alcohol use disorders. Clinical Case Studies, 7, 208–223.PubMedCentralPubMedCrossRef

Deacon, B., & Abramowitz, J. (2006). Anxiety sensitivity and its dimensions across the anxiety disorders. Journal of Anxiety Disorders, 20, 837–857.PubMedCrossRef

Dozois, D. J. A., Westra, H. A., Collins, K. A., Fung, T. S., & Garry, J. K. F. (2004). Stages of change in anxiety: Psychometric properties of the University of Rhode Island Change Assessment (URICA) scale. Behaviour Research and Therapy, 42, 711–729.PubMedCrossRef

Gardenswartz, C. A., & Craske, M. G. (2001). Prevention of panic disorder. Behavior Therapy, 32, 725–737.CrossRef

Hettema, J. M., Prescott, C. A., Myers, J. M., Neale, M. C., & Kendler, K. S. (2005). The Structure of genetic and environmental risk factors for anxiety disorders in men and women. Archives of General Psychiatry, 62, 182–189.PubMedCrossRef

Keough, M. E., & Schmidt, N. B. (2012). Refinement of a brief anxiety sensitivity reduction intervention. Journal of Consulting and Clinical Psychology, 80, 766–772.PubMedCentralPubMedCrossRef

Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 617–627.PubMedCentralPubMedCrossRef

Korte, K. J., & Schmidt, N. B. (2012). Differential prediction of CO₂ challenge as a function of the taxon and complement classes of anxiety sensitivity. Depression and Anxiety, 29, 444–448.CrossRef

Korte, K. J., & Schmidt, N. B. (2013a). High-risk feedback: A brief intervention enhancing motivation to change anxiety. Cognitive Therapy and Research, 37, 332–339.CrossRef

Korte, K. J., & Schmidt, N. B. (2013b). Motivation enhancement therapy reduces anxiety sensitivity. Cognitive Therapy and Research, 37, 1140–1150.CrossRef

Lau, E. X., & Rapee, R. M. (2011). Prevention of anxiety disorders. Current Psychiatry Reports, 13, 258–266.PubMedCrossRef

Lowe, B., Grafe, K., Zipfel, S., Spitzer, R. L., Herrmann-Lingen, C., Witte, S., et al. (2002). Detecting panic disorder in medical and psychosomatic outpatients. Comparative validation of the Hospital anxiety and depression scale, the Patient Health Questionnaire, a screening question and physician’s diagnosis. Journal of Psychosomatic Research, 55, 515–519.CrossRef

Maltby, N., & Tolin, D. (2005). A brief motivational intervention for treatment-refusing OCD patients. Cognitive Behavioral Therapy, 34, 176–184.CrossRef

McConnaughy, E. A., Prochaska, J. O., & Velicer, W. F. (1983). Stages of change in psychotherapy. Measurement and sample profiles. Psychotherapy: Theory Research, and Practice, 20, 368–375.CrossRef

Merlo, L. J., Storch, E. A., Lehmkul, H. D., Murphy, T. K., Goodman, W. K., & Geffken, G. R. (2010). Cognitive behavioral therapy plus motivational interviewing improves outcome for pediatric obsessive-compulsive disorder: A preliminary study. Cognitive Behavioral Therapy, 39, 24–27.CrossRef

Miller, W. R., & Johnson, W. R. (2008). A natural language screening measure for motivation to change. Addictive Behaviors, 33, 1177–1182.PubMedCrossRef

Miller, W. R., & Rollnick, S. (Eds.). (2002). Motivational interviewing: Preparing people for change (2nd ed.). New York: Guillford.

Miller, W. R., Zeben, A., DiClemente, C. C., & Rychtarik, R. G. (1992). Motivational enhancement therapy manual: A clinical research guide for therapists treating individuals with alcohol abuse and dependence. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism.

Murray, C. J. L., Abraham, J., Mohommed, K. A., Alvarado, M., Atkinson, C., Baddour, L. M., & U. S. Burden of Disease collaborators. (2013). The state of US health, 1990–2010: Burden of diseases, injuries, and risk factors. Journal of the American Medical Association, 310, 591–606.PubMedCrossRef

Powers, M. B., Smits, J. A. J., Otto, M. W., Sanders, C., & Emmelkamp, P. M. G. (2009). Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: A randomized placebo controlled trial of yohimbine augmentation. Journal of Anxiety Disorders, 23, 350–356.PubMedCrossRef

Rector, N. A., Szacum-Shimizu, K., & Leybman, M. (2007). Anxiety sensitivity within the anxiety disorders: Disorder-specific sensitivities and depression comorbidity. Behaviour Research and Therapy, 45, 1967–1975.PubMedCrossRef

Reiss, S. (1997). Trait Anxiety: It’s not what you think it is. Journal of Anxiety Disorders, 11, 201–214.PubMedCrossRef

Reiss, S., Peterson, R. A., Gursky, D. M., & McNally, R. J. (1986). Anxiety sensitivity, anxiety frequency and the predictions of fearfulness. Behaviour Research and Therapy, 24, 1–8.PubMedCrossRef

Roy-Byrne, P. P., Craske, M. G., Stein, M. B., Sullivan, G., Bystritsky, A., Katon, W., & Sherbourne, C. D. (2005). A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder. Archives of General Psychiatry, 62, 290–298.PubMedCentralPubMedCrossRef

Schmidt, N. B. (1999). Examination of differential anxiety sensitivities in panic disorder: A test of anxiety sensitivity subdomains in predicting fearful responding to a 35% CO₂ challenge. Cognitive Therapy and Research, 23, 3–19.CrossRef

Schmidt, N. B., & Mallott, M. (2006). Evaluating anxiety sensitivity and other fundamental sensitivities predicting anxiety symptoms and fearful responding to a biological challenge. Behaviour Research and Therapy, 44, 1681–1688.PubMedCrossRef

Schmidt, N. B., Lerew, D. R., & Trakowski, J. H. (1997). Body vigilance in panic disorder: Evaluating attention to bodily perturbations. Journal of Consulting and Clinical Psychology, 65, 214–220.PubMedCrossRef

Schmidt, N. B., Lerew, D. R., & Jackson, R. J. (1999). Prospective evaluation of anxiety sensitivity in the pathogenesis of panic: Replication and extension. Journal of Abnormal Psychology, 108, 532–537.PubMedCrossRef

Schmidt, N. B., Zvolensky, M. J., & Maner, J. K. (2006). Anxiety sensitivity: Prospective prediction of panic attacks and Axis I pathology. Journal of Psychiatric Research, 40, 691–699.PubMedCrossRef

Schmidt, N. B., Eggleston, A. M., Woolaway-Bickel, K., Fitzpatrick, K. K., Vasey, M. W., & Richey, J. A. (2007). Anxiety sensitivity amelioration training (ASAT): A longitudinal primary prevention program targeting cognitive vulnerability. Journal of Anxiety Disorders, 21, 302–319.PubMedCrossRef

Smits, J. A. J., Berry, A. C., Rosenfield, D., Powers, M. B., Behar, E., & Otto, M. W. (2008a). Reducing anxiety sensitivity with exercise. Depression and Anxiety, 25, 689–699.PubMedCrossRef

Smits, J. A. J., Berry, A. C., Tart, C. D., & Powers, M. B. (2008b). The efficacy of cognitive- behavioral interventions for reducing anxiety sensitivity: A meta-analytic review. Behaviour Research and Therapy, 46, 1047–1054.PubMedCrossRef

Spitzer, R. L., Gibbons, M., & Williams, J. B. (1995). Structured clinical interview for Axis I DSM-IV disorders (SCID). Washington: American Psychiatric Association.

Taylor, S., & Cox, B. J. (1998). Anxiety sensitivity: Multiple dimensions and hierarchic structure. Behaviour Research and Therapy, 36, 37–51.PubMedCrossRef

Taylor, S., Koch, D., & McNally, R. J. (1992). How does anxiety sensitivity vary across the anxiety disorders? Journal of Anxiety Disorders, 6, 249–259.CrossRef

Telch, M. J., Lucas, J. A., Schmidt, N. B., Hanna, H. H., Jaimez, T. L., & Lucas, R. A. (1993). Group cognitive-behavioral treatment of panic disorder. Behaviour Research and Therapy, 31, 279–287.PubMedCrossRef

Westra, H. A., & Dozois, D. J. A. (2006). Preparing clients for cognitive behavioral therapy: A randomized pilot study of motivational interviewing for anxiety. Cognitive Therapy Research, 30, 481–498.CrossRef

Westra, H. A., & Phoenix, E. (2003). Motivational enhancement therapy in two refractory cases of anxiety disorder: New responses to treatment refractoriness. Clinical Case Studies, 2, 306–322.CrossRef

Westra, H. A., Arkowitz, H., & Dozois, D. J. A. (2009). Adding motivational interviewing pretreatment to cognitive behavioral therapy for generalized anxiety disorder: A preliminary randomized controlled trial. Journal of Anxiety Disorders, 23, 1106–1117.PubMedCentralPubMedCrossRef

Zinbarg, R. E., Barlow, D. H., & Brown, T. A. (1997). Hierarchical structure and general factor saturation of the anxiety sensitivity index: Evidence and implications. Psychological Assessment, 9, 277–284.CrossRef

Titel: The Use of Motivation Enhancement Therapy to Increase Utilization of a Preventative Intervention for Anxiety Sensitivity
verfasst von: Kristina J. Korte
Norman B. Schmidt
Publikationsdatum: 01.08.2015
Verlag: Springer US
Erschienen in: Cognitive Therapy and Research / Ausgabe 4/2015
Print ISSN: 0147-5916
Elektronische ISSN: 1573-2819
DOI: https://doi.org/10.1007/s10608-014-9668-y

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2015

Preliminary Evidence for the Enhancement of Self-Conducted Exposures for OCD Using Cognitive Bias Modification

Perceived Emotion Control Moderates the Relationship Between Neuroticism and Generalized Anxiety Disorder

Feeling Good and Taking a Chance? Associations of Hypomania Risk with Cognitive and Behavioral Risk Taking

Validation of a Self-Report Measure of Self-Efficacy in Contamination Fear: The Contamination Self-Efficacy Scale (CSES)

Initial Psychometric Properties of the Attentional Fixation on Suicide Experiences Questionnaire